The estimates of relative bioavailability of new SR with IR formulation based on dose-adjusted AUC@-inf were @ % ( @-@ @ ) for the fasted state and @ % ( @-@ @ ) for the fed state , while these estimates comparing new SR with ER formulation were @ % ( @-@ @ ) in the fasted state and @ % ( @-@ @ ) in the fed state .